Michelle Rheault (@rheault_m) 's Twitter Profile
Michelle Rheault

@rheault_m

Ped neph, Division director #NephJC Opinions my own COI: Chinook,Travere,ELOXX,CSL Vifor, R3R,Aurinia,Otsuka. Alis volat propriis.(she/her) Pronounced “row”

ID: 2953885195

linkhttps://scholar.google.ca/citations?hl=en&user=RSBJjqsAAAAJ calendar_today31-12-2014 17:09:47

17,17K Tweet

15,15K Followers

4,4K Following

Ryan Hsi (@stonecrushed) 's Twitter Profile Photo

Higher thiazide doses correlate with greater reductions in urine calcium, which in turn correlate with fewer symptomatic kidney stone events. These results help explain the null results in the NOSTONE trial, which had modest reductions in urine calcium. jamanetwork.com/journals/jaman…

Michelle Rheault (@rheault_m) 's Twitter Profile Photo

I am out of the office to bring my daughter to college for the first time. Your email will be read through tears and returned on Thursday (maybe).

Kidney Research UK (@kidney_research) 's Twitter Profile Photo

8 days left to apply! This second call welcomes research ideas that could help us to understand the impact that Alport syndrome has on hearing and sight as well as kidney problems. Find out more and apply here: bit.ly/3PG99OQ Closes 4 Sept. Prof Danny Gale Rachel Lennon

UMN Medicine (@umn_dom) 's Twitter Profile Photo

Join us today at 12:15 on zoom for #UMNMedicine Grand Rounds as Dr. Patrick Nachman presents, “IgA Nephropathy: an exemplar of drug licensing in a chronic kidney disease." 📅: Today, 8/29 ⏰: 12:15 PM

Join us today at 12:15 on zoom for #UMNMedicine Grand Rounds as Dr. Patrick Nachman presents, “IgA Nephropathy: an exemplar of drug licensing in a chronic kidney disease."

📅: Today, 8/29
⏰: 12:15 PM
KDIGO (@gokdigo) 's Twitter Profile Photo

The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30. You can download the public review draft and share comments via the feedback survey on the KDIGO

The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30.

You can download the public review draft and share comments via the feedback survey on the KDIGO
Howard Liu, MD MBA (@drhowardliu) 's Twitter Profile Photo

Important reminder to subtract something whenever we add another commitment. And mentors can help if you’re ambivalent about letting something else go 🙂

Matthew Sparks, MD (@nephro_sparks) 's Twitter Profile Photo

The American Society of Nephrology Kidney Translation Podcast episode 2 is out ✔️​​​​​​​Issues of gender equity in nephrology ✔️equal access to mentorship and research ✔️opportunities fellowship programs' parental leave policies ✔️representation in RCTs are covered in this episode

The <a href="/ASNKidney/">American Society of Nephrology</a> Kidney Translation Podcast episode 2 is out

✔️​​​​​​​Issues of gender equity in nephrology
✔️equal access to mentorship and research ✔️opportunities fellowship programs' parental leave policies
✔️representation in RCTs are covered in this episode
Howard Crawford (@hccvpdac) 's Twitter Profile Photo

With more doom and gloom coming from the NCI, it’s time to start de-coupling promotions from getting an R01. Look at your colleagues and think about where they’d be if their promotions were inextricably tied to a lottery. We can’t lose our young talent to our intransigence.

Travere Therapeutics (@travererare) 's Twitter Profile Photo

We are excited to announce that our medicine for the treatment of #IgAnephropathy was granted full approval by the FDA. Today’s approval marks an important milestone in transforming treatment for people living with #RareKidneyDisease. Press release: bit.ly/4eakAr1